{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T06:48:33Z","timestamp":1678344513426},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1986,9,1]],"date-time":"1986-09-01T00:00:00Z","timestamp":525916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1986,9]]},"DOI":"10.1007\/bf00253073","type":"journal-article","created":{"date-parts":[[2004,10,3]],"date-time":"2004-10-03T13:37:35Z","timestamp":1096810655000},"page":"88-89","source":"Crossref","is-referenced-by-count":4,"title":["A phase II antiemetic combination (COMD) for cisplatin-induced nausea and vomiting"],"prefix":"10.1007","volume":"18","author":[{"given":"Fausto","family":"Roila","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Basurto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Minotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enzo","family":"Ballatori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Tonato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl 1","key":"CR1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/00003495-198300251-00007","volume":"25","author":"RJ Gralla","year":"1983","unstructured":"Gralla RJ (1983) Metoclopramide: a review of antiemetic trials. Drugs 25 [Suppl 1]: 63?73","journal-title":"Drugs"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/1097-0142(19850601)55:11<2645::AID-CNCR2820551119>3.0.CO;2-J","volume":"55","author":"H-B Krebs","year":"1985","unstructured":"Krebs H-B, Myers MB, Wheelock JB, Goplerud DR (1985) Combination antiemetic therapy in cisplatin-induced nausea and vomiting. Cancer 55: 2645?2648","journal-title":"Cancer"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/1097-0142(19850201)55:3<527::AID-CNCR2820550310>3.0.CO;2-2","volume":"55","author":"MG Kris","year":"1985","unstructured":"Kris MG, Gralla RJ, Tyson LB, Clark RA, Kelsen DP, Reilly LK, Groshen S, Bosl GJ, Kalman LA (1985) Improved control of cisplatin-induced emesis with highdose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients. Cancer 55: 527?534","journal-title":"Cancer"},{"key":"CR4","first-page":"65","volume":"1","author":"R Lane","year":"1982","unstructured":"Lane R, McGee R, Rivkin S (1982) Antiemetic combination (BCDVR) for control of platinum induced emesis. Proc ASCO 1: 65","journal-title":"Proc ASCO"},{"key":"CR5","first-page":"1493","volume":"68","author":"PM Plezia","year":"1984","unstructured":"Plezia PM, Alberts DS, Kessler J, Aapro MS, Graham V, Survit EA (1984) Immediate termination of intractable vomiting induced by cisplatin combination chemotherapy using an intensive five-drug antiemetic regimen. Cancer Treat Rep 68: 1493?1495","journal-title":"Cancer Treat Rep"},{"key":"CR6","first-page":"909","volume":"69","author":"R Rosell","year":"1985","unstructured":"Rosell R, Abab-Esteve A, Ribas-Mundo M, Moreno I (1985) Evaluation of a combination antiemetic regimen including iv high-dose metoclopramide, dexamethasone, and diphenhydramine in cisplatin-based chemotherapy regimens. Cancer Treat Rep 69: 909?910","journal-title":"Cancer Treat Rep"},{"key":"CR7","first-page":"100","volume":"3","author":"KS Sridhar","year":"1984","unstructured":"Sridhar KS, Donnelly E, Rosenfend C (1984) Combination antiemetic regimen (BIRD) including diphenhydramine, droperidol, metoclopramide and dexamethasone in cisplatin base chemotherapy regimens. Proc ASCO 3: 100","journal-title":"Proc ASCO"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00253073.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00253073\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00253073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T11:56:38Z","timestamp":1554292598000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00253073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,9]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1986,9]]}},"alternative-id":["BF00253073"],"URL":"https:\/\/doi.org\/10.1007\/bf00253073","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,9]]}}}